Benefits
Blood pressure reduction
A meta-analysis of 16 randomized trials (810 people) found grape seed extract lowered systolic pressure by about 6 mmHg and diastolic by about 3 mmHg, and systolic by about 8.5 mmHg in people with metabolic syndrome, though results varied widely between trials. An earlier meta-analysis of 9 trials found only a 1.5 mmHg systolic drop, and an 8-week trial in 70 adults found no significant change.
Antioxidant activity in blood markers
In a 4-week crossover trial in 32 people with type 2 diabetes at high cardiovascular risk, 600 mg/day raised whole blood glutathione, a key antioxidant, and lowered fructosamine and high-sensitivity CRP. Total antioxidant status, blood vessel function and insulin resistance did not change significantly.
Mechanism of action
Free radical scavenging
OPCs are polyphenols that neutralize free radicals in laboratory tests. In people, the clearest antioxidant signal so far is a rise in whole blood glutathione in one small trial, while total antioxidant status did not change.
Nitric oxide and blood vessel relaxation
Grape seed polyphenols are proposed to increase nitric oxide in blood vessel walls, which relaxes arteries. This is the main suggested explanation for the blood pressure findings, but it is not settled: blood vessel function did not improve in the type 2 diabetes trial or the 6-week prehypertension trial, and EFSA found no plausible mechanism established for one branded extract.
Clinical trials
Meta-analysis of 16 randomized controlled trials from 12 articles. (Zhang et al. 2016, Medicine (Baltimore))
810 participants across 16 trials.
Systolic pressure fell by about 6.1 mmHg (95% CI -10.7 to -1.4) and diastolic by about 2.8 mmHg, with very high variation between trials (I2 94% for systolic). Drops were also significant in subgroups under 50 and with a BMI of 25 or more, and about 8.5 mmHg systolic in people with metabolic syndrome. The authors called for large, long-term trials. No heart outcomes were measured.
Meta-analysis of 9 randomized controlled trials. (Feringa et al. 2011, J Am Diet Assoc)
390 participants across 9 trials.
Systolic pressure fell by about 1.5 mmHg and heart rate by about 1.4 beats per minute. There was no significant effect on diastolic pressure, cholesterol, triglycerides or CRP.
Randomized, double-blind, placebo-controlled parallel trial of 300 mg/day for 8 weeks; EFSA identified the extract as MegaNatural-BP. (Ras et al. 2013, Br J Nutr)
70 untreated adults with systolic pressure of 120 to 159 mmHg.
Versus placebo, systolic pressure changed by -3.0 mmHg and diastolic by -1.4 mmHg, neither statistically significant. ADMA, plasma renin activity and platelet aggregation were unaffected.
Randomized, double-blind, placebo-controlled parallel trial of 300 mg/day grape seed extract in a juice drink for 6 weeks, followed by 4 weeks without it. (Park et al. 2016, Br J Nutr)
36 middle-aged adults with prehypertension randomized; 29 completed (12 in the extract group).
Systolic pressure fell 5.6% and diastolic 4.7% within the extract group. The systolic change differed significantly from placebo (P = 0.03); the diastolic difference did not (P = 0.08). Pressure returned to baseline after stopping. Flow-mediated dilation, lipids, glucose and oxidized LDL did not change.
Double-blind, randomized, placebo-controlled crossover trial of 600 mg/day for 4 weeks. (Kar et al. 2009, Diabet Med)
32 adults with type 2 diabetes (16 men, 16 women, mean age about 62) at high cardiovascular risk.
After grape seed extract but not placebo, fructosamine fell, whole blood glutathione rose, high-sensitivity CRP fell and total cholesterol decreased slightly (P = 0.05). Endothelial function, HOMA insulin resistance and total antioxidant status did not change significantly.